Todd P Glancy from 4240 1050 S, Fairmount, IN 46928, age 61, Phone: 7659483580

Us Patents

Bone Sialoprotein-Based Compositions For Enhancing Connective Tissue Repair
view source
US Patent:

6458763, Oct 1, 2002
Filed:

Sep 17, 1999
Appl. No.:

09/398330
Inventors:

Dale R. Peterson - Carmel IN
Todd P. Glancy - Fairmount IN
Assignee:

DePuy Orthopeadics - Warsaw IN
International Classification:

A61K 3800
US Classification:

514 8, 424484, 424485, 424486, 424487, 424548, 424549, 514 2, 514 21, 514769, 514770, 5147723, 514773, 514777, 514778, 514779, 514964
Abstract:

The present invention is directed to bioactive compositions that induce the repair of damaged or diseased connective tissues upon contact of the damaged or diseased tissues with the composition in vivo. More particularly the present invention is directed to the use of compositions comprising an effective amount of bone sialoprotein to enhance the repair of damaged or diseased bone.

Bioerodable Polymeric Adhesives For Tissue Repair
view source
US Patent:

6733787, May 11, 2004
Filed:

Sep 19, 2001
Appl. No.:

09/956390
Inventors:

Dale R. Peterson - Carmel IN
Todd P. Glancy - Fairmount IN
Assignee:

DePuy Orthopaedics, Inc. - Warsaw IN
International Classification:

A61K 910
US Classification:

424486, 424426
Abstract:

Methods for tissue repair are provided employing a matrix comprising a biocompatible, bioerodable polymer, said polymer comprising a thermoplastic lactide-containing terpolymer of monomer units derived from lactic acid, glycolic acid, and either caprolactone or valerolactone, which has a water solubility of about 0. 01 to about 500 mg/mL at about 25Â C. and adhesive strength of about 600 to about 150,000 Pa and applying the matrix to a tissue defect. The matrix or adhesive can further comprise a filler or a bioactive agent, or both.

Bioerodable Polymeric Adhesives For Tissue Repair
view source
US Patent:

6923985, Aug 2, 2005
Filed:

Aug 6, 2001
Appl. No.:

09/923118
Inventors:

Dale R. Peterson - Carmel IN, US
Todd P. Glancy - Fairmount IN, US
Assignee:

DePuy Orthopaedics, Inc. - Warsaw IN
International Classification:

A61K009/10
A61K047/34
A61K031/765
C08G063/08
US Classification:

424486, 424 7837, 156332, 5283184, 528931
Abstract:

Improved matrices and adhesives for tissue repair comprising a biocompatible, bioerodable polymer, said polymer comprising a thermoplastic lactide-containing terpolymer of monomer units derived from lactic acid, glycolic acid, and either caprolactone or valerolactone, which has a water solubility of about 0. 01 to about 500 mg/mL at about 25 C. and adhesive strength of about 600 to about 150,000 Pa. The matrix or adhesive can further comprise a filler or a bioactive agent, or both.

Bioerodable Polymeric Adhesives For Tissue Repair
view source
US Patent:

7122205, Oct 17, 2006
Filed:

Mar 29, 2004
Appl. No.:

10/811649
Inventors:

Dale R. Peterson - Carmel IN, US
Todd P. Glancy - Fairmount IN, US
Assignee:

DePuy Products, Inc. - Warsaw IN
International Classification:

A61K 47/34
US Classification:

424486, 424426
Abstract:

Methods for tissue repair are provided employing a matrix comprising a biocompatible, bioerodable polymer, said polymer comprising a thermoplastic lactide-containing terpolymer of monomer units derived from lactic acid, glycolic acid, and either caprolactone or valerolactone, which has a water solubility of about 0. 01 to about 500 mg/mL at about 25 C. and adhesive strength of about 600 to about 150,000 Pa and applying the matrix to a tissue defect. The matrix or adhesive can further comprise a filler or a bioactive agent, or both.

Use Of Untranslated Region Of Osmotin Gene To Enhance Transgene Expression In Plants
view source
US Patent:

8003777, Aug 23, 2011
Filed:

Feb 5, 2008
Appl. No.:

12/012813
Inventors:

Donald J. Merlo - Carmel IN, US
Dong Liu - Carmel IN, US
Stephanie L. Burton - Indianapolis IN, US
Todd P. Glancy - Fairmount IN, US
Assignee:

Dow AgroSciences LLC - Indianapolis IN
International Classification:

C07H 21/04
C12N 15/00
C12N 15/113
C12N 15/63
US Classification:

536 241, 536 231, 800278, 800279, 4353201
Abstract:

The present invention provides methods, vectors and gene constructs for enhancing expression of a recombinant nucleic acid sequence in transgenic plants and plant tissues. According to the present invention, nucleic acid sequences are obtained and/or derived from the 5′ and 3′ untranslated regions of genes encoding osmotin proteins and engineered to flank respective portions of a selected coding region of a vector. The vector construct may be introduced into plants and/or plant tissues through conventional procedures, resulting in enhanced expression of the selected coding region. In a preferred embodiment, the selected coding region is a chimeric gene or gene fragment expressing one or more proteins known to impart a level of insecticidal activity to a transgenic plant and/or plant tissue.

Use Of Untranslated Region Of Osmotin Gene To Enhance Transgene Expression In Plants
view source
US Patent:

8008466, Aug 30, 2011
Filed:

Jun 6, 2006
Appl. No.:

11/448061
Inventors:

Donald Joseph Merio - Carmel IN, US
Dong Liu - Carmel IN, US
Stephanie Love Burton - Indianapolis IN, US
Todd Philip Glancy - Fairmount IN, US
Assignee:

Dow AgroSciences LLC - Indianapolis IN
International Classification:

C07H 21/04
C12N 15/00
C12N 15/113
C12N 15/63
US Classification:

536 241, 536 231, 800278, 800279, 4353201
Abstract:

The present invention provides methods, vectors and gene constructs for enhancing expression of a recombinant nucleic acid sequence in transgenic plants and plant tissues. According to the present invention, nucleic acid sequences are obtained and/or derived from the 5′ and 3′ untranslated regions of genes encoding osmotin proteins and engineered to flank respective portions of a selected coding region of a vector. The vector construct may be introduced into plants and/or plant tissues through conventional procedures, resulting in enhanced expression of the selected coding region. In a preferred embodiment, the selected coding region is a chimeric gene or gene fragment expressing one or more proteins known to impart a level of insecticidal activity to a transgenic plant and/or plant tissue.

Use Of Untranslated Region Of Osmotin Gene To Enhance Transgene Expression In Plants
view source
US Patent:

20050102713, May 12, 2005
Filed:

Nov 7, 2003
Appl. No.:

10/703280
Inventors:

Donald Merlo - Carmel IN, US
Dong Liu - Carmel IN, US
Stephanie Burton - Indianapolis IN, US
Todd Glancy - Fairmount IN, US
International Classification:

A01H001/00
C12N015/82
C07H021/04
C12Q001/68
US Classification:

800278000, 536023200, 435468000
Abstract:

The present invention provides methods, vectors and gene constructs for enhancing expression of a recombinant nucleic acid sequence in transgenic plants and plant tissues. According to the present invention, nucleic acid sequences are obtained and/or derived from the 5′ and 3′ untranslated regions of genes encoding osmotin proteins and engineered to flank respective portions of a selected coding region of a vector. The vector construct may be introduced into plants and/or plant tissues through conventional procedures, resulting in enhanced expression of the selected coding region. In a preferred embodiment, the selected coding region is a chimeric gene or gene fragment expressing one or more proteins known to impart a level of insecticidal activity to a transgenic plant and/or plant tissue.

Plant Production Of Immunoglobulins With Reduced Fucosylation
view source
US Patent:

20070089201, Apr 19, 2007
Filed:

Nov 28, 2003
Appl. No.:

10/536875
Inventors:

Kristen Briggs - Del Mar CA, US
Todd Glancy - Indianapolis IN, US
Mich Hein - Chicago IL, US
Andrew Hiatt - San Diego CA, US
Anton Karnoup - Midland MI, US
W. H. Anderson - Midland MI, US
Dayakar Pareddy - Indianapolis IN, US
Joseph Petolino - Indianapolis IN, US
Beth Rubin-Wilson - Indianapolis IN, US
Doug Taylor - Midland MI, US
Jean Roberts - Indianapolis IN, US
International Classification:

A01H 5/00
C07K 16/18
C12N 5/04
C12N 15/82
US Classification:

800288000, 530387200, 800320100, 435412000, 435468000
Abstract:

This invention provides for the plant production of immunoglobulins, wherein at least a portion of the glycans attached to the immunoglobulins lack fucose. The invention also provides the constructs; plasmids; vectors; transformed plant cells, transformed plant calli; transformed plant tissues (e.g., leaves, seeds, tubers, etc.); transformed whole plants used to produce such immunoglobulins; methods of producing the immunoglobulins; the immunoglobulins produced by the disclosed methods; and the use of such immunoglobulins.